&Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.33M | Buy |
20,475
+8,497
| +71% | +$3.46M | 0.06% | 264 |
|
|
2025
Q1 | $5.96M | Buy |
11,978
+10
| +0.1% | +$4.98K | 0.06% | 262 |
|
|
2024
Q4 | $6.36M | Buy |
11,968
+3,323
| +38% | +$1.77M | 0.08% | 240 |
|
|
2024
Q3 | $5.35M | Buy |
8,645
+5,260
| +155% | +$3.25M | 0.1% | 194 |
|
|
2024
Q2 | $1.87M | Buy |
3,385
+2,170
| +179% | +$1.2M | 0.08% | 219 |
|
|
2024
Q1 | $706K | Sell |
1,215
-262
| -18% | -$152K | 0.1% | 210 |
|
|
2023
Q4 | $784K | Buy |
1,477
+642
| +77% | +$341K | 0.19% | 120 |
|
|
2023
Q3 | $423K | Buy |
835
+70
| +9% | +$35.4K | 0.2% | 96 |
|
|
2023
Q2 | $399K | Hold |
765
| – | – | 0.18% | 101 |
|
|
2023
Q1 | $441K | Buy |
765
+27
| +4% | +$15.6K | 0.21% | 93 |
|
|
2022
Q4 | $406K | Sell |
738
-91
| -11% | -$50.1K | 0.2% | 96 |
|
|
2022
Q3 | $420K | Sell |
829
-13
| -2% | -$6.59K | 0.24% | 93 |
|
|
2022
Q2 | $457K | Hold |
842
| – | – | 0.26% | 89 |
|
|
2022
Q1 | $497K | Buy |
842
+29
| +4% | +$17.1K | 0.28% | 88 |
|
|
2021
Q4 | $542K | Hold |
813
| – | – | 0.33% | 74 |
|
|
2021
Q3 | $464K | Hold |
813
| – | – | 0.3% | 81 |
|
|
2021
Q2 | $410K | Buy |
813
+13
| +2% | +$6.56K | 0.27% | 91 |
|
|
2021
Q1 | $365K | Buy |
800
+130
| +19% | +$59.3K | 0.27% | 91 |
|
|
2020
Q4 | $312K | Sell |
670
-30
| -4% | -$14K | 0.26% | 91 |
|
|
2020
Q3 | $309K | Sell |
700
-100
| -13% | -$44.1K | 0.31% | 75 |
|
|
2020
Q2 | $290K | Buy |
800
+84
| +12% | +$30.5K | 0.35% | 76 |
|
|
2020
Q1 | $203K | Sell |
716
-100
| -12% | -$28.4K | 0.32% | 99 |
|
|
2019
Q4 | $265K | Sell |
816
-100
| -11% | -$32.5K | 0.32% | 109 |
|
|
2019
Q3 | $267K | Sell |
916
-90
| -9% | -$26.2K | 0.35% | 104 |
|
|
2019
Q2 | $295K | Sell |
1,006
-140
| -12% | -$41.1K | 0.41% | 82 |
|
|
2019
Q1 | $314K | Buy |
+1,146
| New | +$314K | 0.45% | 78 |
|